Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ÀÇ ½Å°æº´¼º µ¿Åë ȯÀÚ¿¡ ´ëÇÑ ¿ªÇÐÁ¶»ç

Epidemiology Study of Patients with Neuropathic Pain in Korea

´ëÇѱ¸°­³»°úÇÐȸÁö 2008³â 33±Ç 4È£ p.353 ~ 374
¿øÁ¤¿¬, ±è±â¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
¿øÁ¤¿¬ ( Won Jung-Yeon ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
±è±â¼® ( Kim Ki-Suk ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç

Abstract

ºñ·Ï ½Å°æº´¼º µ¿ÅëÀÌ È¯ÀÚ¿¡°Ô ÁÖ´Â ½É¸®Àû ºÎ´ã¿¡ ´ëÇÏ¿© Àß ¾Ë°í ÀÖÁö¸¸ µ¿ÅëÀÇ ¿ªÇÐÁ¶»ç¿¡ ´ëÇؼ­´Â ¾ÆÁ÷ Àß ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. ½Å°æº´¼º µ¿ÅëÀÇ Á¤È®ÇÑ ¹ßº´·üµµ Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀº µ¥, ÀÌ´Â ¿©·¯°¡Áö »õ·Î¿î ÀÇ·á±â±â°¡ °³¹ßµÇ¾úÁö¸¸ Á¤È®ÇÑ Áø´ÜÀ» ÇÏÁö ¸øÇÏ°í ÀÖÀ¸¸ç, ÀûÀýÇÑ Ä¡·á¸¦ Á¦´ë·Î ÇÏÁö ¸øÇϱ⠶§¹®ÀÌ´Ù. º» ¿¬±¸ÀÇ ¸ñÀûÀº Çѱ¹³» ¸ðµç Á¾·ùÀÇ º´¿ø¿¡¼­ Ä¡·áÇÑ ¸î °¡Áö ƯÁ¤ ½Å°æº´¼º µ¿Åë¿¡ ´ëÇÏ¿© ¿ªÇÐÁ¶»ç¸¦ ½ÃÇàÇÏ´Â °ÍÀÌ´Ù. 2003³â 1¿ùºÎÅÍ 2005³â 12¿ù±îÁö °Ç°­º¸Çè½É»çÆò°¡¿ø(½ÉÆò¿ø)ÀÇ Àü»ê¿¡ ÀÔ·ÂµÈ È¯ÀÚµéÀ» ´ë»óÀ¸·Î Á¶»çÇÑ ½Å°æº´¼º µ¿Åë ȯÀÚ¿Í Ä¡·á ¹ÞÀº °ú ¹× Ä¡·á±â°£ µî¿¡ ´ëÇÏ¿© Á¶»çÇÏ¿´´Ù. ½Å°æº´¼º µ¿Åë ȯÀÚÀÇ ¼ö¿Í À¯º´·üÀ» »ìÆ캸¸é »ïÂ÷½Å°æÅë 77,053¸í (27.6%), ºñÁ¤ÇüÀû ¾È¸éÅë 12,382¸í (4.4%), ¼³ÀÎÈÄ ½Å°æÅë 1,319¸í (0.5%), Æ÷ÁøÈÄ ½Å°æÅë 84,598¸í (30.3¸í), ´ç´¢º´¼º ½Å°æÅë 85,989¸í (30.8%), ºñÁ¤ÇüÀû Ä¡Åë 16,001¸í (5.7%), ¼³Åë 2,133¸í (0.8%) À̸ç, ½Ã°£ÀÌ °æ°úÇÔ¿¡ µû¶ó Æ÷ÁøÈÄ ½Å°æÅë°ú ´ç´¢º´¼º ½Å°æÅëÀº Áõ°¡ÇÏ´Â °æÇâÀ» º¸À̳ª, ±×¿Ü ½Å°æÅëÀº ´ëºÎºÐ Áõ°¡°¡ µÐÈ­µÇ´Â ¾ç»óÀ» º¸¿´´Ù. ´ëºÎºÐÀÇ È¯ÀÚµéÀº 57.6-72.8% ¿¡ À̸£µµ·Ï 1Â÷ ÀÇ·á±â°üÀÎ °³ÀÎÀÇ¿ø¿¡¼­ Ä¡·á¹Þ¾ÒÀ¸³ª ºñÁ¤ÇüÀû Ä¡ÅëÀÇ °æ¿ì¿¡¸¸ 10.3% Á¤µµ·Î 1Â÷ ÀÇ·á±â°ü¿¡¼­ Áø·á¹Þ´Â ºñÀ²ÀÌ ³·¾Ò´Ù. Ä¡°úÀÇ¿ø¿¡ ³»¿øÇϴ ȯÀÚÀÇ ºñÀ²Àº »ïÂ÷½Å°æÅë 3.2%, ºñÁ¤ÇüÀû Ä¡Åë 35.4%, ¼³Åë 15.4%ÀÌ¸ç ±× ¿Ü ³ª¸ÓÁö ½Å°æº´¼º µ¿ÅëÀº ´ëºÎºÐ ÀÇ¿ø¿¡¼­ Ä¡·á¹Þ¾Ò´Ù.

The descriptive epidemiology of specific neuropathic pain disorders has not been well-des-cribed, although the burden of neuropathic pain is well recognized. The true incidence of neuro-pathic pain disorder is unknown, but it is believed to be under diagnosed and treated inade-quately, despite the development of various diagnostic system. The purpose of this study was to report the epidemiology of specific neuropathic pain as managed by all kinds of hospital in Korea. A descriptive analysis of the epidemiology of prevalent trigeminal neuralgia(TN)(n-=77,053 27,6%), atypical facial pain(AFP)(n=12,382 4.4%), glossopharyngeal neuralgia(GN)-(n=1,319 0.5%), post-herpetic neuralgia (PHN)-(n=84,598 30.3%), diabetic neuropathy(DN)-(n=85,989 30.8%), atypical odontalgia (AO)-(n=16,001 5.7%) and glossodynia(GD)(n=2,133 0.8%) and treatment departments and treatment durations from computerized Health Insurance Review and Assessment Service (HIRA) of Korea: January 2003 to December 2005, are reported with rates increasing over time for PHN and DN and decreasing for the other neuropathic pain disorders. Most patients were treated at private clinic record for 57.6-72.8% of patients except OA for 10.3%. The percentage of Dept of dentistry for outpatients was 3.2% for TN, 34.7% for AO and 15.4% for GD. Other neuropathic pain patients visited nearly medical clinic.

Å°¿öµå

½Å°æº´¼º µ¿Åë;¿ªÇÐ;»ïÂ÷½Å°æÅë;ºñÁ¤ÇüÀû ¾È¸éÅë;¼³ÀεΠ½Å°æÅë;Æ÷ÁøÈĽŰæÅë;´ç´¢º´¼º ½Å°æÅë;ºñÁ¤ÇüÀû Ä¡Åë;¼³Åë
Neuropathic pain disorder;Epidemiology;Trigeminal neuralgia;Atypical facial pain;Glossopharyngeal neuralgia;Post-herpetic neuralgia;Diabetic neuropathy;Atypical odontalgia;Glossodynia

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI